| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |